XML 126 R80.htm IDEA: XBRL DOCUMENT v3.19.1
Segment information - Major customers (Details) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Disclosure of major customers [line items]      
Revenue € 288,836 € 127,087 € 129,519
United States      
Disclosure of major customers [line items]      
Revenue 117,609 82,050 88,628
Europe      
Disclosure of major customers [line items]      
Revenue 171,113 45,037 40,884
Gilead | United States      
Disclosure of major customers [line items]      
Revenue € 116,640 € 80,687 € 87,813
Percentage of entity's revenue 40.00% 63.00% 68.00%
Gilead | Europe      
Disclosure of major customers [line items]      
Revenue € 7,793    
Percentage of entity's revenue 3.00%    
AbbVie | Europe      
Disclosure of major customers [line items]      
Revenue € 89,936 € 34,049 € 32,596
Percentage of entity's revenue 31.00% 27.00% 25.00%
Novartis | Europe      
Disclosure of major customers [line items]      
Revenue € 55,218    
Percentage of entity's revenue 19.00% 0.00% 0.00%
Les Laboratoires Servier | Europe      
Disclosure of major customers [line items]      
Revenue € 9,000 € 67 € 265
Percentage of entity's revenue 3.00% 0.00% 0.00%
Revenues by major customers      
Disclosure of major customers [line items]      
Revenue € 278,587 € 114,804 € 120,674
Percentage of entity's revenue 96.00% 90.00% 93.00%